Table 5 Vascular complications and mortality in relation to COVID-19 (N = 24)
Variables | COVID-19 | Total (n = 24) | X2 | P value | ||
|---|---|---|---|---|---|---|
Negative (n = 11) | Positive (n = 13) | |||||
Vascular complications no (%) | ||||||
ICA attenuation | 3 (27.27%) | 1 (7.69%) | 4 (16.67%) | 1.645 | 0.200 | |
ICA thrombosis | 5 (45.45%) | 10 (76.92%) | 15 (62.50%) | 2.517 | 0.113 | |
ICA pseudo aneurysm | 1 (9.09%) | 1 (7.69%) | 2 (8.33%) | 0.015 | 0.902 | |
Cavernous sinus thrombosis | 6 (54.54%) | 10 (76.92%) | 16 (66.67%) | 1.343 | 0.247 | |
Ophthalmic vein thrombosis | 3 (27.27%) | 6 (46.15%) | 9 (37.50%) | 0.906 | 0.341 | |
Mortality, no (%) | ||||||
Negative | 3 (27.27%) | 7 (53.85%) | 10 (41.67%) | 1.731 | 0.188 | |
Positive | 8 (72.73%) | 6 (46.15%) | 14 (58.33%) | |||